Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Debt (2016 - 2025)

STRATA Skin Sciences' Total Debt history spans 13 years, with the latest figure at $15.3 million for Q3 2025.

  • For Q3 2025, Total Debt rose 1.04% year-over-year to $15.3 million; the TTM value through Sep 2025 reached $15.3 million, up 1.04%, while the annual FY2024 figure was $15.2 million, 0.98% up from the prior year.
  • Total Debt for Q3 2025 was $15.3 million at STRATA Skin Sciences, roughly flat from $15.3 million in the prior quarter.
  • Across five years, Total Debt topped out at $15.3 million in Q3 2025 and bottomed at $500000.0 in Q2 2021.
  • The 5-year median for Total Debt is $15.0 million (2023), against an average of $10.9 million.
  • The largest annual shift saw Total Debt tumbled 80.22% in 2021 before it skyrocketed 1379.0% in 2022.
  • A 5-year view of Total Debt shows it stood at $7.3 million in 2021, then increased by 2.15% to $7.5 million in 2022, then surged by 101.23% to $15.0 million in 2023, then rose by 0.98% to $15.2 million in 2024, then grew by 0.78% to $15.3 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Total Debt are $15.3 million (Q3 2025), $15.3 million (Q2 2025), and $15.2 million (Q1 2025).